Tabula Rasa HealthCare — Investor Presentation (May 2023)
35 slides from Tabula Rasa HealthCare's investor presentation, May 17, 2023
Slide 1: Investor Presentation
Copyright © 2023, Tabula Rasa HealthCare, Inc., All Rights Reserved. These materials are confidential and proprietary information of Tabula Rasa HealthCare, Inc. and may not be reproduced in whole or in part without the written consent of Tabula Rasa HealthCare, Inc. | NASDAQ – TRHC. Investor Presen
Slide 2: Safe Harbor
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Safe Harbor This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Secu
Slide 3: – TRHC.
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. 3
Slide 4: Overview of Tabula Rasa
© 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Technology Enabled Solutions 21% Pharmacy Services 79% TPA Services 33% EHR Solutions 22% Risk Adjustment 20% PBM Services 18% MedWise 6% Overview of Tabula Rasa 4 Company Overview 202
Slide 5: Tabula Rasa At a Glance
© 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Tabula Rasa At a Glance 5 1. Since inception 2. Average YoY reduction in medical costs per participant receiving CareKinesis services 3. Represents mid-point of 2023 revenue guidance range
Slide 6: The Tabula Rasa HealthCare Advantage
© 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. The Tabula Rasa HealthCare Advantage Data Driven Medical Management Solutions Data 10+ years of patient, pharmacist and provider data Analysis Proprietary algorithms identify medication-rel
Slide 7: Tabula Rasa HealthCare Evolution
© 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Tabula Rasa HealthCare, formerly known as CareKinesis, founded by Dr. Calvin and Orsula Knowlton Completed its Initial Public Offering and started trading on the Nasdaq Exchange CareKinesis
Slide 8: Management Team Overview
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Management Team Overview 8 Brian W. Adams President and CEO Thomas Cancro, CPA, CFA Chief Financial Officer April Gill Chief Commercial Officer Celynda Tadlock, PharmD, MBA Presid
Slide 9: Strategic Board Refreshment
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Strategic Board Refreshment 9 Derek Schrier Managing Director & CIO, Indaba Capital Management, LP ✓ Deep financial acumen working as an executive in the asset management and inve
Slide 10: PACE Defined
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. 150 PACE programs operate 306 centers across 32 states plus D.C. serving about 64,000 participants The average participant is 77 years old, has 5.8 chronic conditions and visits t
Slide 11: Overview of TRHC's PACE Solutions
© 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Overview of TRHC’s PACE Solutions Clinical and Quality Improvement Solutions for PACE and Non-PACE Populations Complementary Solutions for PACE Populations • Medication fulfillment bundled
Slide 12: CareKinesis PACE Pharmacy
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. CareKinesis® PACE Pharmacy 12 CareKinesis provides PACE-custom pharmacy services plus innovative methods for preventing adverse drug events, increasing participant adherence, and
Slide 13: Value-Based Care Market Opportunity
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Value-Based Care Market Opportunity 13 • PACE is the “gold standard” for value-based care and one of only a few models that provides an integrated care offering for the more than
Slide 14: Dual-Eligible Fact Sheet
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Dual-Eligible Fact Sheet 14 30% 17% 32% Dual-eligibles as a percentage of Medicare’s total spending Dual-eligibles as a percentage of Medicaid’s total population Dual-eligibles as
Slide 15: PACE Growth Dynamics
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. • CMS figures do not include Medicaid-only PACE participants, which account for ~10% of the overall PACE participant base. • Excluding COVID-impacted years of 2020 and 2021, CMS e
Slide 16: What Problem Does MedWise Address?
© 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Prescription medications are the most common clinical intervention in the U.S. and represents a significant pain point for the broader healthcare system What Problem Does MedWise Address? 1
Slide 17: The MedWise Journey
Copyright © 2021 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. The MedWise® Journey 17 Driven by unique and proprietary science and technology *If claims are not available, TRHC can receive medication data from any source. **Includes a review
Slide 18: MedWise Profile
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. • In August 2022, we announced a strategic partnership with Transaction Data Systems (TDS), a leading provider of pharmacy management solutions to community pharmacies. • Use case
Slide 19: Mapping Solutions to Revenue
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Mapping Solutions to Revenue 19 • Medication fulfillment bundled with MedWise® & clinical tele-pharmacy services ❖ Pricing model: Per script (e.g., AWP less discount) plus dispens
Slide 20: Revenue Trends – Growth Continues to Accelerate
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Revenue Trends – Growth Continues to Accelerate 20 1Reflects continuing operations only and excludes discontinued operations from PrescribeWellness, SinfoniaRx, and DoseMe. 2Refle
Slide 21: Quarterly Trend: Key Operating Metric Trends
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Quarterly Trend: Key Operating Metric Trends 21 PACE Backlog ($M) $78 $84 $50 $60 $70 $80 $90 Q4-22 Q1-23 1Defined as the number of PACE participants utilizing at least one of our
Slide 22: Balance Sheet and Cash Flow Highlights
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Balance Sheet and Cash Flow Highlights 22 As of March 31, 2022 Cash and Cash Equivalents $67.2m Convertible debt (due in 2026) $325.0m Q1-23 Capital expenditures + Capitalized sof
Slide 23: Compelling Growth Strategy
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. 23 Compelling Growth Strategy Existing Base ✓ Our existing PACE centers continue to expand their service areas within their state and/or grow participant base. Along with annual d
Slide 24: Outlook: Q2-23 and FY-23
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Outlook: Q2-23 and FY-23 24 Q2-23 Growth (Y/Y) 2023 Growth (Y/Y) Total Revenue ($M) $88 - $90 21% - 24% $355 – $365 19% - 22% Adjusted EBITDA ($M) $3.5 - $4.5 70% - 119% $19 – $22
Slide 25: Adjusted EBITDA Trends
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Adjusted EBITDA Trends • Focused on driving higher profitability and cash flow through a combination of gross margin (beginning in 2024) and operating margin leverage. • 2023 adju
Slide 26: Conclusions: Why We Win
© 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Conclusions: Why We Win 26 We have a deep understanding of the market, with extensive touch points across the entire PACE value chain. TRHC currently services 80%+ of PACE population today
Slide 27: Appendix
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Appendix 27
Slide 28: MedWise Traditional vs Next Generation
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. MedWise® 28 Traditional One-to-one drug analysis Antiquated one-to-one drug interaction software is the current industry standard. Next Generation Simultaneous multi-drug analysis
Slide 29: Proven Outcomes: CMS Enhanced MTM
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Proven Outcomes: CMS Enhanced MTM 29 September 2021: Three-article supplement Association of a MedWise Risk Score™ with Health Care Outcomes Medication-related Problems Identified
Slide 30: Proven Outcomes
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. Proven Outcomes 1. PACE organizations utilizing our medication risk mitigation (i.e., MedWise ®) consumed $5,024 less in total medical costs from 2018 to 2019, $4,386 per particip
Slide 31: GAAP to Non-GAAP Reconciliation
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. GAAP to Non-GAAP Reconciliation 31
Slide 32: GAAP to Non-GAAP Reconciliation
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. GAAP to Non-GAAP Reconciliation 32
Slide 33: GAAP to Non-GAAP Reconciliation
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. GAAP to Non-GAAP Reconciliation 33
Slide 34: GAAP to Non-GAAP Guidance Reconciliation
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. GAAP to Non-GAAP Guidance Reconciliation 34
Slide 35: – TRHC.
Copyright © 2023 Tabula Rasa HealthCare, Inc., All Rights Reserved. May not be used without permission. | NASDAQ – TRHC. 35
Tabula Rasa HealthCare — Investor Presentation (May 2023) on 6ix